Peter Hutt has been a partner or senior counsel specializing in food and drug law in the Washington, D.C., law firm of Covington & Burling since 1968, except when he served as Chief Counsel for the FDA from 1971 to 1975. He is the co-author of a casebook used to teach food and drug law throughout the country and teaches a full course on this subject at Harvard Law School. Hutt has been a member of the Institute of Medicine (IOM) of the National Academy of Sciences (NAS) since it was formed in 1971. He has served on the IOM Executive Committee and other NAS and IOM committees. He recently served as a member of the Working Group on Innovation in Drug Development and Evaluation for President Obama’s Council of Advisors on Science and Technology (PCAST). Hutt served on the Science Review Subcommittee of the FDA Science Board to review the FDA science needs in order to perform its regulatory mission, and published a major analysis that resulted in Congress doubling FDA appropriations. He also recently served on the Panel on the Administrative Restructuring of the National Institutes of Health and on the Working Group to Review Regulatory Activities Within the Division of AIDS of the National Institute of Allergy and Infectious Diseases. He is a member of the Board of Directors of the AERAS Global TB Vaccine Foundation, the Foundation for Biomedical Research, the California Healthcare Institute, the Institute of Health Policy Analysis and the Keck Graduate Institute of Applied Life Sciences, one of the Claremont Colleges. He serves on a wide variety of other academic and scientific advisory boards, on the Board of Directors of venture capital startup companies, and on the Advisory Boards of venture capital firms. Hutt received his B.A. in economics and political science from Yale University, an LLB from Harvard Law School and an LLM in food and drug law from New York University Law School.
